Related Experiment Video
Updated: Jun 21, 2026
04:03
Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians
Published on: September 27, 2024
[COPD: Burden, risk factors and prevalence].
1Zentrum für Klinische Psychologie und Rehabilitation, Universität Bremen, Bremen. nkar@uni-bremen.de
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))
|July 22, 2009
Summary
Chronic Obstructive Pulmonary Disease (COPD) prevalence estimates vary widely due to inconsistent methods. The new GOLD guidelines offer standardized criteria to improve accuracy in assessing COPD
Area of Science:
- Pulmonology and Epidemiology
- Public Health
Context:
- Previous estimates of Chronic Obstructive Pulmonary Disease (COPD) prevalence exhibit significant variability.
- This inconsistency likely stems from diverse diagnostic criteria and methodologies.
- Consequently, the true burden of COPD, including morbidity, mortality, and economic costs, may be underestimated.
Purpose:
- To review current findings on COPD risk factors and burden.
- To highlight the impact of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) strategies, established in 2001, which introduced objective physiological criteria for COPD diagnosis and severity.
- To discuss recent results from the Burden of Obstructive Lung Disease (BOLD) international study.
Summary:
- The review synthesizes current knowledge on COPD epidemiology, risk factors, and disease burden.
- It emphasizes the challenges posed by variable prevalence rates and their impact on understanding COPD's true scope.
- The implementation of GOLD guidelines is expected to improve the reliability of prevalence data and burden assessments.
Impact:
- Standardized GOLD criteria are anticipated to enhance the accuracy of future COPD prevalence rates and burden estimations.
- Improved data quality will enable more effective public health strategies and resource allocation for COPD management.
- This review provides a foundation for understanding the evolving landscape of COPD research and its global impact.
Related Concept Videos
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation